HIV and pregnancy: 2013 guidelines from the French expert working group;Infection par le VIH et grossesse: nouvelles recommandations 2013 du groupe d'experts français

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 7, 2014, Pages 534-548

  Mandelbrot, L ^a   Berrebi A ^b   Matheron, S ^c   Blanche, S ^d   Tubiana, R ^e   Rouzioux, C ^d   Faucher, P ^c   Partisani, M ^f   Boyer, V ^g   Taeron, C ^h   Faye, A ⁱ   Bujan, L ^b   Dabis, F ^j   Warszawski, J ^k   Morlat, P ^l  

^a HÔPITAL LOUIS MOURIER   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g Federation AIDES   (France)

^h Association ARCAT   (France)

ⁱ HÔPITAL ROBERT DEBRÉ   (France)

^j INSERM   (France)

^k Centre National de la Recherche Scientifique   (France)

^l HÔPITAL SAINT ANDRÉ   (France)

more..

Author keywords

Antiretroviral therapy; Childbirth; French guidelines; HIV; Pregnancy

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; STEROID; ZIDOVUDINE;

ANTIVIRAL THERAPY; ARTICLE; BLEEDING; BREAST FEEDING; CESAREAN SECTION; CHORIOAMNIONITIS; DRUG EFFICACY; FEMALE; FETUS RISK; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATERNAL PLASMA; OBSTETRIC PROCEDURE; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RISK REDUCTION; THIRD TRIMESTER PREGNANCY; VIRUS LOAD; COMPLICATION; HIV INFECTIONS; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84905390587     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.01.006     Document Type: Article

References (30)

1. Morlat P et le groupe d'experts. eg. Prise en charge médicale des personnes vivant avec le VIH. Recommandations du groupe d'experts. Rapport 2013 Française LD Paris
2. J. Warszawski, R. Tubiana, J. Le Chenadec, S. Blanche, J.P. Teglas, and C. Dollfus et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort AIDS 22 2008 289 299
3. C. Jasseron, L. Mandelbrot, R. Tubiana, J.P. Teglas, A. Faye, and C. Dollfus et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants for French women? AIDS 22 2008 1503 1511
4. R. Tubiana, J. Le Chenadec, C. Rouzioux, L. Mandelbrot, K. Hamrene, and C. Dollfus et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1) Clin Infect Dis 50 2010 585 596
5. P.J. Read, S. Mandalia, P. Khan, U. Harrisson, C. Naftalin, and Y. Gilleece et al. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS 26 2012 1095 1103
6. J. Sibiude, J. Warszawski, R. Tubiana, C. Dollfus, A. Faye, and C. Rouzioux et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis 54 2012 1348 1360
7. S. Heidari, L. Mofenson, M.F. Cotton, R. Marlink, P. Cahn, and E. Katabira Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children J Acquir Immune Defic Syndr 57 2011 290 296
8. S.W.J. Blanche Tolérance des antirétroviraux durant la grossesse Med Sci (Paris) 29 2013 383 388
9. L.J. Else, S. Taylor, D.J. Back, and S.H. Khoo Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid) Antivir Ther 16 2011 1139 1147
10. USPHS. http://aidsinfo.nih.gov/contentfiles/lvguidelines/Peri- Recommendations.pdf. 2013
11. OMS.http://apps.who.int/iris/bitstream/10665/70891/1/WHO-HIV-2012.6-fre. pdf. 2013
12. J. Sibiude, L. Mandelbrot, S. Blanche, J.L. Chenadec, N. Bouallag-Bonnet, and A. Faye et al. Birth defects and ART in the French Perinatal Cohort, a prospective exhaustive study among 13,124 live births from 1994 to 2010 Conference on Retroviruses and Opportunistic Infections 2013 [Atlanta]
13. S. Blanche, M. Tardieu, P. Rustin, A. Slama, B. Barret, and G. Firtion et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084 1089
14. A. Simon, J. Warszawski, D. Kariyawasam, J. Le Chenadec, V. Benhammou, and P. Czernichow et al. Association of prenatal postnatal exposure to lopinavir-ritonavir adrenal dysfunction among uninfected infants of HIV-infected mothers JAMA 306 2011 70 78
15. I. Andre-Schmutz, L. Dal-Cortivo, E. Six, S. Kaltenbach, F. Cocchiarella, and J. Le Chenadec et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination J Infect Dis 208 2013 235 243
16. O.A. Olivero, L.R. Torres, S. Gorjifard, D. Momot, E. Marrogi, and R.L. Divi et al. Perinatal exposure of Patas Monkeys to antiretroviral nucleoside reverse-transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age J Infect Dis 208 2013 244 248 10.1093/infdis/jit146 [Epub 2013 Apr 4]
17. S.B. Brogly, S. DiMauro, R.B. Van Dyke, P.L. Williams, A. Naini, and D.E. Libutti et al. Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children AIDS Res Hum Retroviruses 27 2011 777 783
18. S.E. Lipshultz, W.T. Shearer, B. Thompson, K.C. Rich, I. Cheng, and E.J. Orav et al. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study) J Am Coll Cardiol 57 2011 76 85
19. V. Benhammou, J. Warszawski, S. Bellec, F. Doz, N. Andre, and B. Lacour et al. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors AIDS 22 2008 2165 2177
20. R.M.L. Tubiana, S. Delmas, J. Le Chenadec, C. Rouzioux, J.M. Tréluyer, and M.L. Chaix et al. LPV/r monotherapy during pregnancy for PMTCT of HIV-1: the PRIMEVA/ANRS 135 randomized trial, pregnancy outcomes 8th Conference on Retroviruses and Opportunistic Infections 2011 [Paper # 125LB]
21. G.P. Taylor, P. Clayden, J. Dhar, K. Gandhi, Y. Gilleece, and K. Harding H.I.V. British Association guidelines for the management of HIV infection in pregnant women HIV Med 13 2012 87 157
22. M. Burgard, C. Jasseron, S. Matheron, F. Damond, K. Hamrene, and S. Blanche et al. Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1 Clin Infect Dis 51 2010 833 843
23. B.A.E. Piel, J.F. Oury, L. Carbillon, and L. Mandelbrot Interruptions médicales de grossesse pour motifs maternels: étude rétrospective multicentrique des indications après la loi de 2001 et avant la loi de bioéthique de 2011 J Gynecol Obstet Biol Reprod (Paris) 42 2013 342 350 10.1016/j.jgyn.2012.12.008
24. N. Briand, J. Warszawski, L. Mandelbrot, C. Dollfus, E. Pannier, and L. Cravello et al. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Clin Infect Dis 57 2013 903 914
25. C.L. Townsend, M. Cortina-Borja, C.S. Peckham, A. de Ruiter, H. Lyall, and P.A. Tookey Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland 2000-2006 AIDS 22 2008 973 981
26. N. Briand, C. Jasseron, J. Sibiude, E. Azria, J. Pollet, and Y. Hammou et al. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010 Am J Obstet Gynecol 209 2013 335 [e1-e12]
27. A.M. Cotter, K.F. Brookfield, L.M. Duthely, V.H. Gonzalez Quintero, J.E. Potter, and M.J. O'Sullivan Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy Am J Obstet Gynecol. 207 2012 482 [e1-5]
28. L. Mandelbrot, C. Jasseron, D. Ekoukou, A. Batallan, A. Bongain, and E. Pannier et al. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales French Perinatal Cohort Am J Obstet Gynecol 200 2009 160 [e1-9]
29. D.J. Jamieson, C.S. Chasela, M.G. Hudgens, C.C. King, A.P. Kourtis, and D. Kayira et al. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial Lancet 379 2012 2449 2458
30. N. Briand, L. Mandelbrot, S. Blanche, R. Tubiana, A. Faye, and C. Dollfus et al. Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy J Acquir Immune Defic Syndr 57 2011 126 135